You are currently browsing the monthly archive for June 2013.


The interest towards traditional medicine is growing in easter asia and europe due to recent migration trends.

Stroke carries a poor prognosis for death and disability.  The international, multicenter, randomized, placebo-controlled, double-blind CHIMES trial is currently testing the hypothesis that a 3-month course of the traditional Chinese medicine MLC601 (NeuroAiD) is superior to placebo in reducing neurological deficit and improving functional outcome after acute ischemic stroke in patients receiving standard stroke care. On Cerebrovascular diseases the main paper description of the study design a population.

Blog Stats

  • 5,349 hits

Developing Medicine and CC


%d bloggers like this: